1. Luque Paz, Damien, Kralovics, Robert, Skoda, Radek C. . Genetic basis and molecular profiling in myeloproliferative neoplasms. In Blood, 141, 1909-1921. doi:10.1182/blood.2022017578. https://pubmed.ncbi.nlm.nih.gov/36347013/
2. Klampfl, Thorsten, Gisslinger, Heinz, Harutyunyan, Ashot S, Cazzola, Mario, Kralovics, Robert. 2013. Somatic mutations of calreticulin in myeloproliferative neoplasms. In The New England journal of medicine, 369, 2379-90. doi:10.1056/NEJMoa1311347. https://pubmed.ncbi.nlm.nih.gov/24325356/
3. Furuya, Chiho, Hashimoto, Yoshinori, Morishita, Soji, Ando, Miki, Komatsu, Norio. . MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan. In Hematology (Amsterdam, Netherlands), 28, 2229131. doi:10.1080/16078454.2023.2229131. https://pubmed.ncbi.nlm.nih.gov/37378567/
4. Cleyrat, Cédric, Girard, Romain, Choi, Eun H, Carillo, Serge, Wilson, Bridget S. 2017. Gene editing rescue of a novel MPL mutant associated with congenital amegakaryocytic thrombocytopenia. In Blood advances, 1, 1815-1826. doi:10.1182/bloodadvances.2016002915. https://pubmed.ncbi.nlm.nih.gov/29296828/
5. Wicke, Daniel C, Meyer, Johann, Buesche, Guntram, Baum, Christopher, Modlich, Ute. 2009. Gene therapy of MPL deficiency: challenging balance between leukemia and pancytopenia. In Molecular therapy : the journal of the American Society of Gene Therapy, 18, 343-52. doi:10.1038/mt.2009.233. https://pubmed.ncbi.nlm.nih.gov/19844195/
智鼠故事 
